| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FRMD6 mRNA | CTD | PMID:22079256 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:727810 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FRMD6 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1550347 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FRMD6 mRNA | CTD | PMID:21570461 |
| afimoxifene | multiple interactions | EXP | | 6480464 | 4-hydroxytamoxifen inhibits the reaction [Estrogens results in decreased expression of FRMD6 mRNA] | CTD | PMID:21233418 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of FRMD6 protein | CTD | PMID:20106945 |
| ammonium chloride | affects expression | ISO | RGD:727810 | 6480464 | Ammonium Chloride affects the expression of FRMD6 mRNA | CTD | PMID:16483693 |
| arsenite(3-) | affects expression | EXP | | 6480464 | arsenite affects the expression of FRMD6 mRNA | CTD | PMID:22959463 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1550347 | 6480464 | Benzo(a)pyrene results in decreased expression of FRMD6 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:1550347 | 6480464 | Benzo(a)pyrene results in increased expression of FRMD6 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1550347 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of FRMD6 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of FRMD6 mRNA | CTD | PMID:20106945 |
| clofibrate | increases expression | ISO | RGD:1550347 | 6480464 | Clofibrate results in increased expression of FRMD6 mRNA | CTD | PMID:17585979 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of FRMD6 mRNA | CTD | PMID:19320972 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of FRMD6 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of FRMD6 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of FRMD6 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of FRMD6 mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of FRMD6 mRNA | CTD | PMID:19167446 |
| crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of FRMD6 mRNA | CTD | PMID:18687144 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of FRMD6 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:1550347 | 6480464 | Cyclosporine results in increased expression of FRMD6 mRNA | CTD | PMID:19770486 |
| dibutyl phthalate | increases expression | ISO | RGD:1550347 | 6480464 | Dibutyl Phthalate results in increased expression of FRMD6 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:1550347 | 6480464 | Dibutyl Phthalate results in increased expression of FRMD6 mRNA | CTD | PMID:17361019 PMID:21266533 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:727810 | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FRMD6 mRNA | CTD | PMID:20360939 |
| paracetamol | affects expression | ISO | RGD:1550347 | 6480464 | Acetaminophen affects the expression of FRMD6 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of FRMD6 mRNA | CTD | PMID:21420995 |
| pirinixic acid | multiple interactions | ISO | RGD:1550347 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FRMD6 mRNA | CTD | PMID:19710929 |
| resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of FRMD6 mRNA | CTD | PMID:19167446 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of FRMD6 mRNA | CTD | PMID:19167446 |
| troglitazone | decreases expression | ISO | RGD:727810 | 6480464 | troglitazone results in decreased expression of FRMD6 mRNA | CTD | PMID:21515302 |
| valproic acid | affects expression | ISO | RGD:1550347 | 6480464 | Valproic Acid affects the expression of FRMD6 mRNA | CTD | PMID:17292431 |
| valproic acid | increases expression | ISO | RGD:1550347 | 6480464 | Valproic Acid results in increased expression of FRMD6 mRNA | CTD | PMID:21427059 |